EP2402015A3 - Methode zur Produktion von Sophorolipiden durch Fermentation von Candida bombicola - Google Patents

Methode zur Produktion von Sophorolipiden durch Fermentation von Candida bombicola Download PDF

Info

Publication number
EP2402015A3
EP2402015A3 EP11007833A EP11007833A EP2402015A3 EP 2402015 A3 EP2402015 A3 EP 2402015A3 EP 11007833 A EP11007833 A EP 11007833A EP 11007833 A EP11007833 A EP 11007833A EP 2402015 A3 EP2402015 A3 EP 2402015A3
Authority
EP
European Patent Office
Prior art keywords
fermentation
candida bombicola
producing sophorolipids
sophorolipids
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11007833A
Other languages
English (en)
French (fr)
Other versions
EP2402015A2 (de
Inventor
designation of the inventor has not yet been filed The
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polytechnic Institute of NYU
Original Assignee
Polytechnic Institute of NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polytechnic Institute of NYU filed Critical Polytechnic Institute of NYU
Publication of EP2402015A2 publication Critical patent/EP2402015A2/de
Publication of EP2402015A3 publication Critical patent/EP2402015A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
EP11007833A 2004-03-24 2005-03-24 Methode zur Produktion von Sophorolipiden durch Fermentation von Candida bombicola Withdrawn EP2402015A3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/807,961 US7262178B2 (en) 2003-03-24 2004-03-24 Treatment of sepsis and septic shock
EP05730352A EP1729782A4 (de) 2004-03-24 2005-03-24 Behandlung und prophylaxe von sepsis und septischem schock

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
EP05730352.1 Division 2005-03-24

Publications (2)

Publication Number Publication Date
EP2402015A2 EP2402015A2 (de) 2012-01-04
EP2402015A3 true EP2402015A3 (de) 2012-02-15

Family

ID=35064250

Family Applications (3)

Application Number Title Priority Date Filing Date
EP11007833A Withdrawn EP2402015A3 (de) 2004-03-24 2005-03-24 Methode zur Produktion von Sophorolipiden durch Fermentation von Candida bombicola
EP11007832A Withdrawn EP2402014A3 (de) 2004-03-24 2005-03-24 Verwendung von Sophorolipiden, welche durch Fermentation von Candida bombicola hergestellt wurden
EP05730352A Withdrawn EP1729782A4 (de) 2004-03-24 2005-03-24 Behandlung und prophylaxe von sepsis und septischem schock

Family Applications After (2)

Application Number Title Priority Date Filing Date
EP11007832A Withdrawn EP2402014A3 (de) 2004-03-24 2005-03-24 Verwendung von Sophorolipiden, welche durch Fermentation von Candida bombicola hergestellt wurden
EP05730352A Withdrawn EP1729782A4 (de) 2004-03-24 2005-03-24 Behandlung und prophylaxe von sepsis und septischem schock

Country Status (4)

Country Link
US (3) US7262178B2 (de)
EP (3) EP2402015A3 (de)
CA (1) CA2557671C (de)
WO (1) WO2005094268A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040101488A1 (en) * 2000-03-24 2004-05-27 Balaram Ghosh Method for the prevention of septic shock lethality using curcumin
US7262178B2 (en) * 2003-03-24 2007-08-28 Polytechnic University Treatment of sepsis and septic shock
US20070042003A1 (en) * 2005-08-19 2007-02-22 Webber Robert J Method of effecting a mammalian model of sepsis, severe sepsis, or septic shock
WO2008097971A2 (en) * 2007-02-06 2008-08-14 The Research Foundation Of State University Of New York Methods for treating diseases of altered ige regulation
US20100130442A1 (en) * 2007-05-07 2010-05-27 Raj Wadgaonkar Lung Injury Treatment
US20120142621A1 (en) * 2010-12-03 2012-06-07 Biomedica Management Corporation Purified Ethyl Ester Sophorolipid for the Treatment of Sepsis
US9884986B2 (en) 2014-04-21 2018-02-06 Baker Hughes, A Ge Company, Llc Method of using biosurfactants as acid corrosion inhibitors in well treatment operations
EP3658151A1 (de) * 2017-07-25 2020-06-03 DSM IP Assets B.V. Verwendung von sophorolipiden als futterzusatz
WO2019020578A1 (en) * 2017-07-25 2019-01-31 Dsm Ip Assets B.V. USE OF SOPHOROLIPIDS AS ADDITIVES FOR ANIMAL FEEDING

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900366A (en) * 1992-06-18 1999-05-04 Institut Français Du Petrole Production of sophorolipid acetate acids from oils or esters
US6596265B1 (en) * 1998-05-29 2003-07-22 Institut Français du Pétrole Use of sophorolipids comprising diacetyl lactones as agent for stimulating skin fibroblast metabolism

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5428895A (en) * 1977-08-01 1979-03-03 Kao Corp Dehydration purification of fermentation products
JPS54109913A (en) * 1978-02-17 1979-08-29 Kao Corp Preparation of glycolipid ester
JPS55303A (en) * 1978-03-03 1980-01-05 Kao Corp Hydroxyalkyl etherified glycolipid ester and its preparation
US5597573A (en) * 1989-05-04 1997-01-28 Igen, Inc. Lipid-A analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities
US5466675A (en) * 1992-02-04 1995-11-14 Piljac; Goran Immunological activity of rhamnolipids
US5648343A (en) * 1994-02-28 1997-07-15 The University Of Georgia Research Foundation Method for treating LPS-mediated disorders
FR2720941B1 (fr) * 1994-06-13 1996-08-23 Inst Francais Du Petrole Utilisation des sophorolipides et compositions cosmétiques et dermatologiques.
FR2735979B1 (fr) * 1995-06-28 1997-08-14 Inst Francais Du Petrole Utilisation comme substances therapeutiquement actives ou produits cosmetiques des sophorolipides, en particulier pour le traitement de la peau
FR2757766B1 (fr) * 1996-12-27 1999-02-19 Inst Francais Du Petrole Utilisation des sophorolipides en tant qu'agent stimulateur du metabolisme des fibroblastes dermiques
WO2004044216A1 (en) * 2002-11-06 2004-05-27 Polytechnic University Antimicrobial properties of various forms of sophorolipids
US7262178B2 (en) * 2003-03-24 2007-08-28 Polytechnic University Treatment of sepsis and septic shock

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900366A (en) * 1992-06-18 1999-05-04 Institut Français Du Petrole Production of sophorolipid acetate acids from oils or esters
US6596265B1 (en) * 1998-05-29 2003-07-22 Institut Français du Pétrole Use of sophorolipids comprising diacetyl lactones as agent for stimulating skin fibroblast metabolism

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KANDIL E K: "Sophorolipids block lethal effects of septic shock", 20030901, vol. 197, no. 3S, 1 September 2003 (2003-09-01), pages S40 - S41, XP008079960 *
ROBERT N GLENNS: "Structures and Properties of Sophorolipids from Candida bombicola", THESIS MCGILL UNIVERSITY MONTRÉAL,, 1 December 2003 (2003-12-01), pages 1 - 84, XP007920052, ISBN: 0-612-98529-6 *

Also Published As

Publication number Publication date
WO2005094268A3 (en) 2007-04-26
EP2402015A2 (de) 2012-01-04
US7968522B2 (en) 2011-06-28
US7772193B2 (en) 2010-08-10
EP2402014A3 (de) 2012-02-15
CA2557671C (en) 2011-01-18
WO2005094268A2 (en) 2005-10-13
US20040214795A1 (en) 2004-10-28
US20070203077A1 (en) 2007-08-30
US7262178B2 (en) 2007-08-28
CA2557671A1 (en) 2005-10-13
EP2402014A2 (de) 2012-01-04
US20070249542A1 (en) 2007-10-25
EP1729782A4 (de) 2010-11-10
EP1729782A2 (de) 2006-12-13

Similar Documents

Publication Publication Date Title
EP2402015A3 (de) Methode zur Produktion von Sophorolipiden durch Fermentation von Candida bombicola
EP2270056A3 (de) Reinigung von Streptococcus-kapselpolysaccharid
DE60238745D1 (de) Glucosamin und verfahren zur herstellung von glucosamin aus mikrobieller biomasse
WO2006026008A3 (en) Method and apparatus for improved ultrasonic strain measurements of soft tissue
WO2005051233A3 (en) Computer-aided tissue engineering of a biological body
WO2007126727A8 (en) WATER SOLUBLE β-GLUCAN, GLUCOSAMINE, AND N-ACETYLGLUCOSAMINE COMPOSITIONS AND METHODS FOR MAKING THE SAME
EP2330203A3 (de) RNA-Konstrukte
WO2005106090A3 (en) Preform produced by electrospinning, method for producting the same and use of such a preform
EP2071020A3 (de) Gewebeimplantat
EP2325339A3 (de) Verfahren und zusammensetzungen zur Erzeugung menschlicher keimlinien-Antikörpergene
TW200801030A (en) Methods of producing C-aryl glucoside SGLT2 inhibitors
HUP0401874A2 (en) Telerecorder or medical tools movable stock receiver and method parts of human body dimension scanning
EP1764295A3 (de) Freizeitfahrzeug
AU2001245461A1 (en) Product and method for biological anchoring of connective tissue to bone
DE602004018297D1 (de) Verfahren zur kollagenextraktion das mikrobielle fermentierung umfasst
EP1862433A4 (de) Personalisierter synthetischer diamant mit verschiedenen farben, erhalten aus keratin (lebender oder toter) menschen oder tiere und herstellungsverfahren dafür
EP2287293A3 (de) Thermophile Bakterienstämme zur Herstellung von Ethanol
EP1437368A4 (de) Zusammensetzung zur polymerisierenden immobilisierung biologischer moleküle und verfahren zur herstellung dieser zusammensetzung
EP1764100A3 (de) Zusammensetzungen und Methoden zur Reduzierung des vaginalen pHs
EP2230249A3 (de) Antigen/Antikörper oder Ligand/Rezeptor glycosylierter Spezifität Austauscher
EP2434022A3 (de) Verwendung von A33-Antigenen und JAM-IT
WO2007064304A8 (en) Biocompatible composition and uses thereof
ATE447333T1 (de) Verfahren zur herstellung eines nahrungsmittelzusatzes, ein zusatz und seine verwendung
WO2002033052A3 (de) Verfahren zur in-vitro-herstellung von vitalem, biologischem ersatzgewebe unter verwendung von zellkulturen und einem trägermaterial
EP1482483A3 (de) Vorrichtung, Verfahren und Programm zur Sprechratenumwandlung

Legal Events

Date Code Title Description
AC Divisional application: reference to earlier application

Ref document number: 1729782

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/7016 20060101AFI20120111BHEP

Ipc: A61P 31/04 20060101ALI20120111BHEP

Ipc: A61K 31/00 20060101ALI20120111BHEP

Ipc: C12P 19/62 20060101ALI20120111BHEP

RIN1 Information on inventor provided before grant (corrected)

Inventor name: GROSS, RICHARD A.

17P Request for examination filed

Effective date: 20120815

17Q First examination report despatched

Effective date: 20121105

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20141001